Concepedia

Loredana Santo

LS

14

Publications

1K

Citations

13

H-Index

2005

Active since

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Division of Cancer Epidemiology and Genetics

National Cancer Institute

University of Turin

Loredana Santo is an author at Harvard University specializing in immunology, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

2005–2023

14

Publications

14

Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma

Marco Ladetto, G Pagliano, Simone Ferrero et al. · Journal of Clinical Oncology · 2010 · 267 citations · Full text

, , +19

Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma

Güllü Görgün, Elisabetta Calabrese, Ender Soydan et al. · Blood · 2010 · 228 citations · Full text

Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease

Homare Eda, Loredana Santo, Marc N. Wein et al. · Journal of Bone and Mineral Research · 2016 · 98 citations · Full text

Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Ola Landgren, Jonathan N. Hofmann, Charlene M. McShane et al. · JAMA Oncology · 2019 · 90 citations · Full text

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome

Marco Ladetto, Sonia Vallet, Andreas Trojan et al. · Blood · 2005 · 86 citations · Full text

Rows per page

1–5 of 14